1. F. de Clerck andJ.L. David,Pharmacological control of platelet and red blood cell function in the microcirculation. J. Cardiovasc. Pharmac.3, 1399–1412 (1981).
2. H.R. Baumgartner andG.V.R. Born,Effects of 5-hydroxytryptamine on platelet aggregation, Nature218, 137–141 (1968).
3. D.J. Bouillin, D.G. Grahame-Smith, R.P.J. Grimes andM.F. Woods,Resuspension of platelets: enhanced 5-hydroxytryptamine-induced aggregation in chlorpromazine-treated patients due to changes in platelet properties, Br. J. Clin. Pharmac.2, 37–39 (1975).
4. S.E. Ball, D.J. Bouillin andP.A.M. Glenton,Interactions between noradrenaline and 5-hydroxytryptamine involving platelet aggregation, J. Physiol.272, 98P-99P (1977).
5. E.M.M. Besterman andM.P.T. Gillet,Influence of lysolecithin on platelet aggregation initiated by 5-hydroxytryptamine, Nature241, 223–224 (1973).